Concerns over the Collectibility of Operating Loans and Allowance for Doubtful Accounts
First written in FY2017. 11 of 23 entries say "Worsened", first in FY2018. Latest entry: FY2026.
TRUST Holdings moved to the "Worse" side of this theme in 2021, 5 years before the typical company in this theme (2026).
3 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「In the consolidated balance sheet for the current consolidated fiscal year, loans receivable of ¥1,100.000 million and a related allowance for doubtful accounts of ¥990.447 million were recognized.」
Loans receivable to a specified medical corporation amounted to ¥1,100.000 million, with a corresponding allowance for doubtful accounts of ¥990.447 million, both up from the previous fiscal year. - FY2026-H1WorsenedAnnual report
「Loans receivable ¥824.947 million ¥991.197 million / Allowance for doubtful accounts △¥293.642 million △¥293.806 million」
Loans receivable increased from ¥824.947 million at the end of the previous consolidated fiscal year to ¥991.197 million, while the allowance for doubtful accounts edged up from ¥293.642 million to ¥293.806 million. - FY2025Loans receivable increased, while the allowance for doubtful accounts decreasedAnnual report
「In the consolidated balance sheet for the current consolidated fiscal year, loans receivable of ¥824.947 million and a related allowance for doubtful accounts of ¥290.947 million were recognized.」
Loans receivable to a specified medical corporation increased from ¥632.685 million to ¥824.947 million, while the allowance for doubtful accounts decreased from ¥381.380 million to ¥290.947 million. - FY2025-H1Provision for doubtful accounts decreased, while the allowance balance increasedAnnual report
「Provision for doubtful accounts ¥37.782 million ¥28.843 million」
Provision for doubtful accounts for the current interim consolidated accounting period was ¥28.843 million, down from ¥37.782 million in the same period of the previous year. Meanwhile, the allowance for doubtful accounts increased from the end of the previous fiscal year. - FY2024WorsenedAnnual report
「In the consolidated balance sheet for the current consolidated fiscal year, loans receivable of ¥632.685 million and a related allowance for doubtful accounts of ¥381.380 million were recognized. These loans receivable comprise ¥632.685 million lent to a specified medical corporation in connection with the Medical Services business conducted mainly by the consolidated subsidiary トラストメディカルサポート株式会社, against which an allowance for doubtful accounts of ¥381.380 million has been recognized.」
Loans receivable to a specified medical corporation amounted to ¥632.685 million, with a corresponding allowance for doubtful accounts of ¥381.380 million, both up from the previous fiscal year. - FY2024-Q3RestatedAnnual report
「The Medical Services business remained generally steady in terms of revenue, supported by rental income and other income from the Miyako Geriatric Health Services Facility, Fukuoka Shinwa Hospital and Ishida Hospital, among others. However, it reported an operating loss due to the recognition of provision for doubtful accounts.」
Although rental income and other income in the Medical Services business remained generally steady, the recognition of provision for doubtful accounts continues to be cited as a factor behind the operating loss. - FY2024-Q2WorsenedAnnual report
「Provision for doubtful accounts △ ¥2.335 million ¥37.782 million」
Provision for doubtful accounts increased from negative ¥2.335 million in the same period of the previous year to ¥37.782 million, becoming a factor in the Medical Services business's operating loss. - FY2023WorsenedAnnual report
「These loans receivable include ¥549.064 million lent to a specified medical corporation in connection with the Medical Services business conducted mainly by the consolidated subsidiary トラストメディカルサポート株式会社, and an allowance for doubtful accounts of ¥319.064 million has been recognized against these loans.」
Loans receivable to a specified medical corporation amounted to ¥549.064 million, with a corresponding allowance for doubtful accounts of ¥319.064 million; both the loans and the allowance increased from the previous fiscal year. - FY2023-Q2MitigatedAnnual report
「Provision for doubtful accounts ¥417 thousand △ ¥2.335 million」
Provision for doubtful accounts for the cumulative second quarter was negative ¥2.335 million, and a reduction in the allowance was reported. - FY2022WorsenedAnnual report
「These loans receivable include ¥539.000 million lent to a specified medical corporation in connection with the Medical Services business conducted mainly by the consolidated subsidiary トラストメディカルサポート株式会社, and an allowance for doubtful accounts of ¥275.000 million has been recognized against these loans.」
The disclosure specifies loans receivable of ¥539.000 million to a specified medical corporation in the Medical Services business and a corresponding allowance for doubtful accounts of ¥275.000 million. - FY2021-Q3WorsenedAnnual report
「The Medical Services business remained generally steady, mainly on rental income from the Miyako Geriatric Health Services Facility and Fukuoka Shinwa Hospital, among others. For monetary receivables, however, we revised assumptions, including the timing of the end of the COVID-19 pandemic, and increased the allowance for doubtful accounts.」
Assumptions including the timing of the end of the COVID-19 pandemic were revised, and the allowance for doubtful accounts on monetary receivables was increased. - FY2019-Q3MitigatedAnnual report
「As a result of securing the doubtful receivables, provision for doubtful accounts included in selling, general and administrative expenses decreased by ¥23.998 million.」
Securing the doubtful receivables reduced provision for doubtful accounts by ¥23.998 million. - FY2019-Q2MitigatedAnnual report
「As a result of securing the doubtful receivables, provision for doubtful accounts included in selling, general and administrative expenses decreased by ¥23.998 million.」
Securing the doubtful receivables reduced provision for doubtful accounts by ¥23.998 million. - FY2019-Q1MitigatedAnnual report
「As a result of securing the doubtful receivables, provision for doubtful accounts included in selling, general and administrative expenses decreased by ¥28.961 million.」
Securing the doubtful receivables reduced provision for doubtful accounts by ¥28.961 million. - FY2018WorsenedAnnual report
「A net amount was recognized after offsetting provision for doubtful accounts of ¥417.453 million on loans to Trust Vision Co., Ltd., RV Trust Co., Ltd., Trust Bio Co., Ltd., Trust Home Energy Co., Ltd. and Trust Network Co., Ltd. against a reversal of ¥4.802 million in the allowance for doubtful accounts on loans to Trust Patrol Co., Ltd.」
Provision for doubtful accounts of ¥417.453 million was recognized for loans to subsidiaries and other entities, representing a substantial increase in the allowance for collection concerns. - FY2018-Q2RestatedAnnual report
「Provision for doubtful accounts ¥9.187 million」
Provision for doubtful accounts of ¥9.187 million was recognized for the cumulative second quarter. - FY2018-Q1Expanded the scope to include provisions for general receivablesAnnual report
「Beginning with the first quarter of the current consolidated fiscal year, an allowance for doubtful accounts for general receivables has been recognized based on the historical loss rate, and ¥12.232 million was recognized as provision for doubtful accounts.」
In addition to the previous concerns over loans receivable, the Company began recognizing an allowance for general receivables based on the historical loss rate and recorded ¥12.232 million as provision for doubtful accounts. - FY2017MaterialisedAnnual report
「In addition, ¥34.7 million relating to a portion of loans receivable was recognized as provision for doubtful accounts.」
¥34.7 million relating to a portion of loans receivable was recognized as provision for doubtful accounts.